Egrifta (tesamorelin) is formed with growth hormone-releasing issue (GRF).

Egrifta is employed to scale back excess fat round the abdomen that’s caused by taking sure HIV medications. This condition is additionally known as lipodystrophy (LYE-poe-DIS-troe-fee).

Egrifta isn’t a weight-loss medication and will not be accustomed treat fat.

Submit your review

Create your own review

Average rating:  
 0 reviews
  • Egrifta
  • Get emergency medical help if you have any of these signs of an allergic reaction to Egrifta: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using Egrifta and call your doctor at once if you have a serious side effect such as:

    swelling in your hands, ankles, or feet;
    pain or stiffness in your muscles or joints;
    pain in your arms or legs;
    wrist pain or numbness;
    numbness or tingling in your hands or fingers;
    pounding heartbeats or fluttering in your chest;
    high blood sugar (increased thirst, increased urination, hunger, dry mouth, fruity breath odor, drowsiness, dry skin, blurred vision, weight loss);
    Less serious Egrifta side effects may include:

    depressed mood, sleep problems (insomnia);
    night sweats;
    mild rash or itching;
    muscle spasm;
    nausea, vomiting, upset stomach;
    pain, redness, itching, swelling, bruising, bleeding, or other irritation where the injection was given;
  • The recommended dose of EGRIFTA® is 2 mg injected subcutaneously once a day. The recommended injection site is the abdomen. Injection sites should be rotated to different areas of the abdomen. Do not inject into scar tissue, bruises or the navel.